Andreas Rosenwald
安德烈亚斯·罗森瓦尔德
MD
Professor and Chair, Institute of Pathology病理学研究所教授兼主任
👥Biography 个人简介
Andreas Rosenwald is a leading molecular hematopathologist known for seminal gene expression profiling studies in DLBCL. His work with Louis Staudt's group established the GCB/ABC molecular subclassification of DLBCL and revealed its prognostic and therapeutic significance.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
DLBCL Gene Expression Profiling
Co-authored landmark studies using DNA microarrays to identify GCB and ABC subtypes of DLBCL with distinct survival outcomes and biology.
Molecular Pathology of Lymphoma
Developed translational molecular pathology approaches bridging gene expression data with routine pathological diagnosis.
WHO Classification Contributions
Contributed expert analysis of DLBCL molecular subtypes to WHO 2016 and 2022 classification updates.
Representative Works 代表性著作
The Use of Molecular Profiling to Predict Survival After Chemotherapy for Diffuse Large-B-Cell Lymphoma
New England Journal of Medicine (2002)
Demonstrated GEP-based DLBCL subclassification predicts survival independently of clinical IPI score.
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of DLBCL
Journal of Experimental Medicine (2003)
Identified PMBL as a distinct DLBCL entity with unique gene expression and clinical features.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elaine Jaffe
National Cancer Institute, NIH
Nancy Lee Harris
Massachusetts General Hospital, Harvard Medical School
Philippe Gaulard
Henri Mondor Hospital, Paris Est University
Louis Staudt
National Cancer Institute, NIH
关注 安德烈亚斯·罗森瓦尔德 的研究动态
Follow Andreas Rosenwald's research updates
留下邮箱，当我们发布与 Andreas Rosenwald（University of Würzburg）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment